Offer - Urjas Oil for just ₹ 1
Symbiva 100 Octacap is a commercial drug that is prescribed in the form of Capsule. Primarily, it is used for the treatment of Asthma. Other than this, Symbiva 100 Octacap has some other therapeutic uses, which have been discussed ahead.
Medical history of the patient along with age and gender determines the dosage of Symbiva 100 Octacap. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. This information has been provided in detail in the dosage section.
The most common side effects of Symbiva 100 Octacap are Nasopharyngitis, Headache, Back Pain. Besides the aforementioned side effects, there are other adverse effects of Symbiva 100 Octacap as well, which are listed below. These side effects of Symbiva 100 Octacap are usually temporary and subside with the completion of treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
In addition, Symbiva 100 Octacap's effect is Moderate during pregnancy and Moderate for lactating mothers. It is important to know if Symbiva 100 Octacap has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Symbiva 100 Octacap related warnings section.
Some other conditions that can be affected by Symbiva 100 Octacap are listed in the contraindications section below.
Drug reaction of Symbiva 100 Octacap with other medicines has been reported. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Symbiva 100 Octacap is considered safe while driving, and is addictive.
Symbiva 100 Octacap is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Is the use of Symbiva 100 Octacap safe for pregnant women?
Pregnant women may experience moderate side effects from Symbiva. It is best to stop taking Symbiva immediately and inform your doctor if you notice any discomfort.
Is the use of Symbiva 100 Octacap safe during breastfeeding?
Symbiva can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Symbiva 100 Octacap on the Kidneys?
There are no side effects of Symbiva on the kidneys.
What is the effect of Symbiva 100 Octacap on the Liver?
Symbiva does not damage the liver.
What is the effect of Symbiva 100 Octacap on the Heart?
Symbiva is rarely harmful for the heart.
If you are suffering from any of the following diseases, you should not take Symbiva 100 Octacap unless your doctor advises you to do so -
Is this Symbiva 100 Octacap habit forming or addictive?
No, you will not get addicted to Symbiva 100 Octacap.
Is it safe to drive or operate heavy machinery when consuming?
Symbiva 100 Octacap will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Symbiva 100 Octacap should be used only after doctor's advice.
Is it able to treat mental disorders?
No, the use of Symbiva 100 Octacap in mental disorders is not effective.
Interaction between Food and Symbiva 100 Octacap
Taking Symbiva 100 Octacap with food is safe.
Interaction between Alcohol and Symbiva 100 Octacap
Taking Symbiva 100 Octacap with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Perforomist® (formoterol fumarate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 224
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 595-596
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 356-366
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 231
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Entocort® Ec (budesonide)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Pulmicort Respules™ (budesonide)
Product Description [Internet]: SYMBICORT. AstraZeneca
